[Federal Register Volume 61, Number 232 (Monday, December 2, 1996)]
[Notices]
[Page 63849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-30537]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Commission on Dietary Supplement Labels; Notice of Meeting No. 7

AGENCY: Office of Disease Prevention and Health Promotion.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) is providing 
notice of the seventh meeting of the Commission on Dietary Supplement 
Labels.

DATES: The Commission intends to hold its meeting on December 16, 1996 
from 9:00 a.m. to approximately 12:00 noon, E.S.T. in the Potomac Room, 
Sheraton City Centre, 1143 New Hampshire Ave. N.W., Washington, D.C. 
20037. The meeting is open to the public; seating is limited.

FOR FURTHER INFORMATION CONTACT:
Kenneth D. Fisher, Ph.D., Executive Director, Commission on Dietary 
Supplement Labels, Office of Disease Prevention and Health Promotion, 
Room 738G, Hubert H. Humphrey Building, 200 Independence Ave. S.W., 
Washington, D.C. 20201, (202) 690-7102.

SUPPLEMENTARY INFORMATION: Public Law 103-417, Section 12, authorized 
the establishment of a Commission on Dietary Supplement Labels whose 
seven members have been appointed by the President. The appointments to 
the Commission by the President and the establishment of the Commission 
by the Secretary of Health and Human Services reflect the commitment of 
the President and the Secretary to the development of a sound and 
consistent regulatory policy on labeling of dietary supplements.
    The Commission is charged with conducting a study and providing 
recommendations for regulation of label claims and statements for 
dietary supplements, including the use of supplemental literature in 
connection with their sale and, in addition, procedures for evaluation 
of label claims. The Commission is expected to evaluate how best to 
provide truthful, scientifically valid, and non-misleading information 
to consumers in order that they may make informed health care choices 
for themselves and their families. The Commission's study report may 
include recommendations on legislation, if appropriate and necessary.
    The Commission meeting agenda will include approval of minutes of 
the previous meeting, review of draft materials, and continuation of 
discussion of key issues related to labeling of dietary supplements 
that may be included in the Commission's forthcoming report.
    The meeting is open to the public. If you will require a sign 
language interpreter, please call Sandra Saunders (202) 690-7102 by 
4:30 p.m. E.S.T. on December 6, 1996.

    Dated: November 22, 1996.
Linda D. Meyers,
Acting Deputy Director, Office of Disease Prevention and Health 
Promotion, U.S. Department of Health and Human Services.
[FR Doc. 96-30537 Filed 11-29-96; 8:45 am]
BILLING CODE 4160-17-M